Fortress Biotech, Inc.FBIONASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -57.90% | -24.20% | +0.84% | +10.18% | +20.52% |
| Gross Profit Growth | -67.01% | -33.13% | +18.80% | +37.33% | +27.10% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +162.68% | +159.33% | +54.21% | +46.75% | +38.32% |
| Weighted Average Shares Diluted Growth | +162.68% | +159.33% | +54.21% | +62.82% | +68.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +33.00% | -32.41% | +81.11% | +51.58% | +67.13% |
| Inventory Growth | +6.93% | +41.40% | +18.11% | +32.67% | +0.25% |
| Asset Growth | -15.59% | -13.91% | +8.15% | +9.75% | +42.74% |
| Book Value per Share Growth | -51.69% | -61.11% | -37.34% | +67.43% | +90.88% |
| Debt Growth | -3.27% | -14.26% | -16.27% | -21.72% | -4.52% |
| R&D Expense Growth | -53.58% | -29.38% | -84.15% | -35.87% | -97.80% |
| SG&A Expenses Growth | +1.20% | +18.17% | +43.04% | +86.13% | -20.82% |